Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury

Conditions

• Acquired Bleeding Disorder
• Trauma

Interventions

• DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S